INT121333

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.65
First Reported 2004
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 11
Total Number 11
Disease Relevance 18.17
Pain Relevance 0.72

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (HEY1) protein binding transcription factor activity (HEY1) DNA binding (HEY1)
transcription factor binding (HEY1) cytoplasm (HEY1)
Anatomy Link Frequency
medial 1
HEY1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Catecholamine 7 99.98 Very High Very High Very High
rheumatoid arthritis 141 99.84 Very High Very High Very High
imagery 5 91.72 High High
guanethidine 1 84.04 Quite High
cva 9 75.08 Quite High
palliative 41 64.16 Quite High
Etanercept 8 51.12 Quite High
Infliximab 6 36.68 Quite Low
ischemia 6 25.00 Low Low
Pain 5 25.00 Low Low
Disease Link Frequency Relevance Heat
Pulmonary Disease 536 100.00 Very High Very High Very High
Heart Failure 496 100.00 Very High Very High Very High
Cv General 4 Under Development 192 100.00 Very High Very High Very High
Myocardial Infarction 99 100.00 Very High Very High Very High
Cardiovascular Disease 15 100.00 Very High Very High Very High
Heart Rate Under Development 7 100.00 Very High Very High Very High
Hypertension 4 100.00 Very High Very High Very High
Pheochromocytoma 1 100.00 Very High Very High Very High
Chronic Renal Failure 441 99.84 Very High Very High Very High
Rheumatoid Arthritis 143 99.84 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In a behavioural intervention study, patients receiving CHF education on techniques to elicit a relaxation response experienced physical and emotional benefits [21].
Localization (education) of CHF associated with myocardial infarction
1) Confidence 0.65 Published 2010 Journal BMC Health Serv Res Section Body Doc Link PMC2851714 Disease Relevance 0.37 Pain Relevance 0
Moreover, patients with severe to very severe COPD, CHF or CRF who want to spend their end-of-life period as they want, should probably leave better advance directives.
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
2) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.32 Pain Relevance 0
1.1 What are the self-perceived symptoms and care needs of patients with severe to very severe COPD, CHF or CRF and to what extent do they differ from each other?
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
3) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.45 Pain Relevance 0
4.1 How do patients with severe to very severe COPD, CHF or CRF and their closest relatives perceive end-of-life care planning (i.e. communication about survival prognosis and life-sustaining treatments) with the treating physician?
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
4) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.92 Pain Relevance 0
2.1 How are the self-perceived symptoms of patients with severe to very severe COPD, CHF or CRF perceived by their closest relatives?
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
5) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.92 Pain Relevance 0
A recent study in 18 patients with COPD, CHF or CRF suggests that decreased independence and social isolation imposes a considerable burden of care on the family.[10] Additionally, Barnes and colleagues have shown that carers of CHF patients have other characteristics than carers of patients with cancer and need practical and emotional support.[27] At present, it remains unknown whether and to what extent self-perceived symptoms and care needs of patients with severe to very severe COPD, CHF or CRF may result in an extra caregiver burden for close relatives.
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease, cancer and heart failure
6) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.79 Pain Relevance 0
1.1 What are the self-perceived symptoms and care needs of patients with severe to very severe COPD, CHF or CRF and to what extent do they differ from each other?
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
7) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.45 Pain Relevance 0
2.2 Whether and to what extent do self-perceived symptoms and care needs of patients with severe to very severe COPD, CHF or CRF affect caregiver burden?
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease and heart failure
8) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 1.96 Pain Relevance 0
Management of these patients should prevent, relieve and/or soothe self-perceived symptoms and care needs to optimise daily functioning and stabilize disease-specific health status. [5-9] The management of patients with severe to very severe COPD, CHF or CRF should probably be a holistic type of care, equally concerned with physical, psychosocial and spiritual aspects of each patient.[10]
Localization (severe) of CHF associated with chronic renal failure, pulmonary disease, disease and heart failure
9) Confidence 0.25 Published 2008 Journal BMC Palliat Care Section Body Doc Link PMC2391145 Disease Relevance 2.11 Pain Relevance 0.06
contributes to the etiology of CHF in RA.
Localization (etiology) of CHF associated with cv general 4 under development and rheumatoid arthritis
10) Confidence 0.25 Published 2005 Journal Arthritis Res Ther Section Body Doc Link PMC1257451 Disease Relevance 1.37 Pain Relevance 0.33
The concomitant development of myocardiopathy and coronary vascular lesions or coronary and carotid artery intimal medial thickening by catecholamine toxicity is reflected by the frequent primary presentation of patients with catecholamine-secreting pheochromocytoma with cardiovascular disease, ie, hypertension arrhythmias, AMI, SCD, CHF, and vascular disease, which represents a clear example of the primary deleterious impact of catecholamines on the entire cardiovascular system causing adrenergic cardiovascular disease.
Localization (secreting) of CHF in medial associated with heart rate under development, cardiomyopathy, catecholamine, increased venous pressure under development, pheochromocytoma, toxicity, cardiovascular disease, hypertension and myocardial infarction
11) Confidence 0.11 Published 2004 Journal Am J Ther Section Abstract Doc Link 15356432 Disease Relevance 2.50 Pain Relevance 0.33

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox